Every Form 4 that Curtiss-Wright Corp. (CW) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow CW and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full CW filings page.
CURTISS WRIGHT CORP (CW) director Larry D. Wyche reported selling 100 shares of common stock on 2026-08-28 at a price of $596.74 per share. Following this open-market sale, he directly holds 1,414 shares. A footnote states the sale was made in compliance with the company's share ownership guidelines.
CURTISS WRIGHT CORP (CW) reported an insider transaction by its EVP & Chief Growth Officer, the reporting person John C. Watts. On August 27, 2026, the reporting person disposed of 1,035 shares of CURTISS WRIGHT CORP common stock, reported as a sale.
According to the footnote, these shares were contributed to an exchange fund in return for shares of that fund, with the CURTISS WRIGHT CORP common stock valued at $619.46 per share, equal to the closing price on August 26, 2026. After this transaction, the reporting person directly held 2,736 shares of CURTISS WRIGHT CORP common stock. The filing does not indicate that the transaction was made under a Rule 10b5-1 trading plan.
Curtiss-Wright Corp director Jeffrey J. Lyash purchased additional common stock. On 2026-08-10, he bought 209.3801 shares of Curtiss-Wright common stock in a purchase in open market or private transaction at a price of $711.62 per share. Following this transaction, he directly owns 257.3801 shares of Curtiss-Wright common stock.
Curtiss-Wright executive George P. McDonald, Executive VP and Corporate Secretary, acquired 25 shares of common stock through a grant/award transaction. The shares were priced at $634.88 per share and were purchased under the company’s Employee Stock Purchase Plan using accumulated payroll deductions over a six-month offering period.
After this ESPP purchase, McDonald directly holds 4,235 common shares. The footnotes explain that the plan provides a 15% discount to the average selling price of Curtiss-Wright stock on June 30, 2026, the last day of the offering period, when determining the purchase price.
Curtiss-Wright Corporation executive John C. Watts increased his direct ownership through the company’s employee stock purchase plan. He acquired 9 shares of common stock at a purchase price of $634.88 per share under the Issuer’s Employee Stock Purchase Plan, funded via prior payroll deductions.
Following this ESPP transaction, Watts directly holds 3,771 shares of Curtiss-Wright common stock. Under the plan’s terms, the purchase price reflects a 15% discount to the average selling price of the company’s common stock on June 30, 2026, the last day of the offering period.
CURTISS WRIGHT CORP Executive VP and COO Kevin Rayment acquired 26 shares of common stock through the company’s Employee Stock Purchase Plan (ESPP). The shares were credited on an offering period ending June 30, 2026, at a purchase price of $634.88 per share. After this ESPP acquisition, Rayment directly holds 31,519 shares. The ESPP uses payroll deductions over a six‑month period and provides a 15% discount based on the average selling price on the last day of the offering period. The transaction is described as exempt under Rule 16b‑3(d) and Rule 16b‑3(c).
Curtiss-Wright Corporation Executive VP and CFO K. Christopher Farkas acquired 21 shares of common stock through the company’s Employee Stock Purchase Plan. The shares were purchased for $634.88 per share at the end of a six-month offering period that concluded on June 30, 2026, using payroll deductions and a 15% discount formula. Following this ESPP transaction, he directly holds 4,274 shares of Curtiss-Wright common stock.
Curtiss-Wright Chair and CEO Lynn M. Bamford acquired additional common stock through the company’s Employee Stock Purchase Plan. On the reported date, Bamford obtained 17 shares at a transaction price of $634.88 per share via payroll deductions under the ESPP. Following this acquisition, Bamford directly holds 45,651 shares of Curtiss-Wright common stock.
Curtiss-Wright Corporation executive John C. Watts reported a small open-market sale of company stock. As EVP & Chief Growth Officer, he sold 200 shares of common stock at a price of $770.56 per share in a single transaction. After the sale, he directly holds 3,762 shares of Curtiss-Wright common stock.
The transaction was carried out under a pre-arranged Rule 10b5-1 trading plan maintained by his financial advisor and adopted by Watts. The filing notes that the sale was made in compliance with the company’s share ownership guidelines, which allow sales as long as he remains in compliance with those guidelines.
Curtiss-Wright Chair and CEO Lynn M. Bamford sold 2,500 shares of Common Stock in an open-market transaction. The shares were sold at an average price of $758.20 per share, and Bamford now directly holds 45,634 shares after the sale.
According to the disclosure, the transaction was executed under a pre-arranged Rule 10b5-1 trading plan adopted by the executive and administered by a financial advisor. The filing also notes that the sale was made in compliance with the company’s share ownership guidelines, and that the reported price reflects an average of multiple trades between $754.05 and $766.75 per share.
Curtiss-Wright Corp senior vice president and corporate controller Gary A. Ogilby reported a planned sale of 399 shares of common stock. The open-market sale was executed at an average price of $721.95 per share, in multiple trades between $705.34 and $736.99. After the transaction, he directly holds 2,172 shares. The sale was carried out under a Rule 10b5-1 trading plan adopted on March 10, 2026 and in line with the company’s share ownership guidelines, which allow sales while maintaining required ownership levels.
Curtiss-Wright Corp Chair and CEO Lynn M. Bamford reported an open-market sale of 2,500 shares of Common Stock at an average price of $721.72 per share. Following the transaction, Bamford directly holds 48,134 shares.
The filing notes the sale was made under a Rule 10b5-1 trading plan adopted on March 10, 2026 and administered by the executive’s financial advisor. It also states the sale was made in line with the company’s share ownership guidelines, which allow sales as long as required ownership levels are maintained. The price reflects multiple trades between $703.54 and $739.63 per share.
MINOR GLENDA J reported acquisition or exercise transactions in this Form 4 filing.
Curtiss-Wright director Glenda J. Minor received a grant of 20 shares of common stock on May 29, 2026, valued at $747.61 per share, as part of her board compensation. The shares were issued under the company’s 2024 Omnibus Incentive Plan, and she now directly holds 2,491.01 shares in total.
Wallace Peter C reported acquisition or exercise transactions in this Form 4 filing.
Curtiss-Wright director Peter C. Wallace reported receiving 221 shares of common stock as a deferred restricted stock award. The shares were issued under the company’s 2024 Omnibus Incentive Plan as part of his non-employee director compensation. Following this grant, he directly holds 6,209 shares.
Curtiss-Wright EVP & Chief Growth Officer John C. Watts sold 220 shares of common stock in an open-market transaction and now holds 3,962 shares directly. The shares were sold at an average price of $752.91 per share.
The sale was carried out under a pre-arranged Rule 10b5-1 trading plan adopted on February 25, 2026 and managed by his financial advisor, and was described as being in compliance with the company’s share ownership guidelines.
Curtiss-Wright Corp director Glenda J. Minor acquired 221 shares of common stock as a grant under the company’s 2024 Omnibus Incentive Plan. The shares were awarded at a reported price of $735.34 per share, increasing her direct holdings to 2,471.01 shares.
According to the footnotes, this grant represents 20% of a $125,000 restricted stock award that Minor elected to receive in five equal annual installments beginning May 12, 2024. The number of shares was calculated using a $115.24 closing price on February 16, 2021 and includes dividend credits, while the price is based on the closing market price on May 12, 2026.
Lyash Jeffrey J. reported acquisition or exercise transactions in this Form 4 filing.
Curtiss-Wright Corp director Jeffrey J. Lyash received a grant of 48 shares of common stock as a board compensation award. The shares, valued at $35,000 based on a $724.43 closing price on the grant date, are restricted and vest after a service-based period.
Curtiss-Wright Corporation Senior VP & Corporate Controller Gary A. Ogilby reported an open-market sale of 252 shares of Common Stock on March 18, 2026 at an average price of $689.14 per share. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan adopted on September 11, 2025. Following this sale, Ogilby directly holds 2,571 shares of Curtiss-Wright common stock.
Curtiss-Wright Corporation Executive VP and CFO K. Christopher Farkas reported an open-market sale of 1,265 shares of common stock at an average price of $689.69 per share. The sale was executed under a pre-arranged Rule 10b5-1 trading plan maintained by his financial advisor. Following this transaction, Farkas directly holds 4,253 shares of Curtiss-Wright common stock. The shares were sold in multiple trades at prices ranging from $681.18 to $699.31 per share.
Curtiss-Wright EVP & Chief Growth Officer John C. Watts exercised 512 restricted stock units into common shares and sold 220 shares. The RSUs were granted on March 16, 2023 under the 2014 Omnibus Incentive Plan and cliff vested after a three-year period.
The 220 common shares were sold on the open market at an average price of $678.11 per share, in multiple trades between $671.53 and $681.02. According to the disclosure, the sale was made to cover tax obligations related to the vesting, and Watts remains in compliance with the company’s share ownership guidelines.
Following these transactions, Watts directly holds 4,182 shares of Curtiss-Wright common stock and 895 restricted stock units, including dividend credits earned on prior grants.
Curtiss-Wright Senior VP & Treasurer Robert F. Freda reported equity award vesting and a small share sale. On March 16, 2026, 296 restricted stock units granted on March 16, 2023 under the 2014 Omnibus Incentive Plan cliff vested and converted into common stock at a $0.00 exercise price.
On March 17, 2026, he sold 140 shares of common stock in open-market transactions at an average price of $678.61 per share. Footnotes explain the sale was made to cover tax obligations in line with company share ownership guidelines, and that he remains in compliance. After the transactions, he directly holds 5,343 common shares, including dividend credits on prior grants.
Curtiss-Wright Senior VP & Corp Controller Gary A. Ogilby reported a combination of equity vesting and a small share sale. On March 16, 2026, 400 shares of common stock were acquired at $0.00 per share through the vesting and conversion of restricted stock units granted in 2023 under the company’s 2014 Omnibus Incentive Plan. On March 17, 2026, he sold 148 shares of common stock at an average price of $678.30 per share. Footnotes state the sale was made to cover tax obligations associated with the vesting and that he remains in compliance with the company’s share ownership guidelines. Following these transactions, he directly holds 2,823 shares of common stock and 4,420 restricted stock units, including dividend credits.
Curtiss-Wright executive George P. McDonald reported routine equity compensation activity, including an RSU vesting and a small share sale. On March 16, 2026, 350 restricted stock units granted on March 16, 2023 vested and were converted into 350 shares of common stock under the company’s 2014 Omnibus Incentive Plan, with no exercise price as they were granted as an employee benefit.
On March 17, 2026, he sold 151 shares of common stock in open-market transactions at an average price of $678.07 per share. A footnote explains the sale was made in line with Curtiss-Wright’s share ownership guidelines, allowing a portion of the vesting award to be sold to cover tax obligations from the vesting, and states he remains in compliance with those guidelines. After these transactions, he directly holds 4,210 shares of common stock and 1,112 restricted stock units, with share totals including dividend credits on prior grants.
Curtiss-Wright Executive VP and COO Kevin Rayment exercised 2,504 restricted stock units into the same number of common shares on March 16, 2026, stemming from a March 16, 2023 RSU grant that cliff-vested after three years.
On March 17, 2026, he completed an open-market sale of 907 common shares at an average price of $677.38 per share, with trades executed between $671.52 and $681. The company notes these shares were sold in line with share ownership guidelines to cover tax obligations related to the vesting. Following the transactions, Rayment directly holds 31,493 common shares and 3,928 RSUs, including dividend credits.
Curtiss-Wright Executive VP and CFO Christopher K. Farkas reported the vesting of restricted stock units and a related share sale. On March 16, 2026, 2,183 restricted stock units granted on March 16, 2023 under the 2014 Omnibus Incentive Plan cliff vested into common stock with no exercise price as an employee benefit.
Following vesting, he held 6,436 common shares, then on March 17, 2026 he sold 918 common shares in open-market transactions at an average price of $677.46 per share. The sale was made to cover tax obligations associated with the vesting, in line with company share ownership guidelines, and left him with 5,518 common shares and 9,366 restricted stock units, including dividend credits.
Curtiss-Wright Chair and CEO Lynn M. Bamford reported a routine combination of RSU vesting and share sale. On March 16, 2026, 7,667 restricted stock units granted on March 16, 2023 under the 2014 Omnibus Incentive Plan cliff vested into common stock at no cash exercise price as an employee benefit. Following this, she held 14,614 RSUs, including dividend credits. On March 17, 2026, she executed an open-market sale of 3,225 common shares at an average price of $676.70 per share, with individual trades ranging from $669.05 to $681. The footnotes state these shares were sold in line with company share ownership guidelines to cover tax obligations from the vesting, and that she remains in compliance. After the sale, she directly owns 50,634 common shares.
Watts John C reported acquisition or exercise transactions in this Form 4 filing.
Curtiss-Wright Corp reported that EVP & Chief Growth Officer John C. Watts received a grant of 183 time-based restricted stock units under the company’s 2024 Omnibus Incentive Plan. Each RSU represents one share of common stock and will cliff vest three years after the March 9, 2026 grant date. Following this award, his reported RSU total is 1,407 units, including dividend credits earned on prior grants.
Freda Robert F reported acquisition or exercise transactions in this Form 4 filing.
Curtiss-Wright Corp reported that Senior VP & Treasurer Robert F. Freda received a grant of 82 restricted stock units (RSUs) on March 9, 2026 under the company’s 2024 Omnibus Incentive Plan. Each RSU represents one share of common stock and will cliff vest after a three-year period from the grant date.
The RSUs were granted as an employee benefit with no purchase price. Following this award and related dividend credits on prior grants, Freda now holds a total of 4,565 RSUs directly.
Ogilby Gary A reported acquisition or exercise transactions in this Form 4 filing.
Curtiss-Wright Corporation reported that Senior VP & Corporate Controller Gary A. Ogilby received a grant of 108 restricted stock units under the company’s 2024 Omnibus Incentive Plan. Each RSU represents a contingent right to one share of common stock, granted as an employee benefit with no cash purchase price.
The RSUs will cliff vest after a three-year vesting period from the March 9, 2026 grant date. Following this award, Ogilby now holds 4,820 RSUs directly, a figure that also reflects dividend credits earned on prior outstanding grants.
Curtiss-Wright executive George P. McDonald reported an equity award and corrected his share count. He received a grant of 304 time-based restricted stock units under the 2024 Omnibus Incentive Plan, each representing one share of common stock, which will cliff vest after a three-year period from the March 9, 2026 grant date.
The filing also corrects his previously reported common stock ownership, noting that 2,064 shares acquired through employee benefit transactions before he became an executive officer were inadvertently omitted from his earlier Form 3. Following these updates, he directly holds 4,011 shares of common stock and 1,462 restricted stock units, including dividend credits on prior grants.
Rayment Kevin reported acquisition or exercise transactions in this Form 4 filing.
Curtiss-Wright Executive VP and COO Kevin Rayment received a grant of 652 time-based restricted stock units under the company’s 2024 Omnibus Incentive Plan. Each unit represents a contingent right to one share of common stock and will cliff vest after a three-year period from the March 9, 2026 grant date.
The units were granted as an employee benefit with no purchase price, and Rayment’s total reported restricted stock unit balance after this award is 6,432 units, which includes dividend credits earned on prior grants.
Farkas K Christopher reported acquisition or exercise transactions in this Form 4 filing.
Curtiss-Wright Executive VP and CFO K. Christopher Farkas received a grant of 645 restricted stock units (RSUs) on March 9, 2026. These RSUs were granted as an employee benefit under the company’s 2024 Omnibus Incentive Plan and carry no purchase price.
Each RSU represents a contingent right to receive one share of Curtiss-Wright common stock, with the award cliff vesting after a three-year period from the grant date. Following this grant, Farkas holds 11,549 RSUs in total, a figure that also reflects dividend credits earned on prior outstanding grants.
Bamford Lynn M reported acquisition or exercise transactions in this Form 4 filing.
Curtiss-Wright Corp reported that Chair and CEO Lynn M. Bamford received a grant of 2,735 time-based restricted stock units (RSUs) under the company’s 2024 Omnibus Incentive Plan. Each RSU represents a contingent right to receive one share of common stock.
The RSUs will cliff vest after a three-year vesting period from the March 9, 2026 grant date, aligning the award with longer-term performance. The grant was made as an employee benefit with no cash price on the grant date. Following this award, Bamford directly holds 22,281 shares and RSUs, a figure that includes dividend credits earned on prior grants.
Curtiss-Wright Corporation’s Executive VP and CFO, K. Christopher Farkas, reported an open-market sale of 3,105 shares of common stock at an average price of $694.51 per share. The sale was executed under a pre-arranged Rule 10b5-1 trading plan and in line with company share ownership guidelines. Following this transaction, he directly holds 4,253 shares of Curtiss-Wright common stock.
Curtiss-Wright director Anthony J. Moraco received an annual equity award of 256 shares of common stock on February 4, 2026. The shares were granted under the company’s 2024 Omnibus Incentive Plan as restricted stock for his service on the board.
The award value was $160,000, calculated using the closing share price of $624.93 on the grant date and rounded down to the nearest whole share. Restrictions lapse after one year or earlier if his board service ends due to death, disability, or failure to be reelected. Following this grant, Moraco directly holds 5,446 shares of Curtiss-Wright common stock.
Curtiss-Wright Corporation director Larry D. Wyche reported an equity grant of restricted common stock. On February 4, 2026, he acquired 128 shares of common stock at a reference price of $624.93 per share under the company’s 2024 Omnibus Incentive Plan.
The award represents half of a $160,000 annual restricted stock grant for non-employee directors, with the number of shares determined by dividing the grant value by the closing price and rounding down. Wyche elected to defer receipt of the remaining 128 shares to a later date. Following this transaction, he beneficially owned 1,514 common shares directly. Restrictions on the granted shares generally lapse after one year or earlier upon death, disability, or failure to be reelected.
Curtiss-Wright executive John C. Watts reported routine share transactions in company stock. On February 3, 2026, he acquired 1,354 shares of common stock through a performance share grant under the 2014 Long Term Incentive Plan, based on three-year total shareholder return versus a peer group.
On February 4, 2026, Watts sold 652 shares of common stock at an average price of $625.57 per share, in line with company share ownership guidelines that allow sales to cover individual income tax obligations from vesting. After these transactions, he directly owned 3,890 Curtiss-Wright common shares.
Curtiss-Wright senior vice president and treasurer Robert F. Freda reported an equity award vesting and a related share sale. On February 3, 2026, he acquired 784 shares of common stock through a performance share grant under the 2014 Long Term Incentive Plan, based on three-year total shareholder return versus a peer group, at a reference price of $674.32 per share.
On February 4, 2026, Freda sold 418 shares of common stock at an average price of $626.95, with individual trades ranging from $611.26 to $658.97. The sale was conducted under company share ownership guidelines to cover income tax obligations from the vesting. After these transactions, he directly held 5,187 shares of Curtiss-Wright common stock.
Curtiss-Wright Corporation Executive VP and COO Kevin Rayment reported stock transactions related to a long-term incentive award. On February 3, 2026, he acquired 6,618 shares of common stock through a performance share grant under the 2014 Long Term Incentive Plan, based on the company’s three-year total shareholder return versus its peer group, at a reference price of $674.32 per share.
On February 4, 2026, he sold 2,634 shares of common stock, in transactions averaging $626.33 per share, with actual prices ranging from $608.82 to $660.05. The filing states these sales were made in line with the company’s share ownership guidelines, allowing the executive to sell part of the vested shares to cover individual income tax obligations from the award vesting. After these transactions, he directly owned 29,896 shares of Curtiss-Wright common stock.
Curtiss-Wright Corporation’s Executive VP and CFO K. Christopher Farkas reported a performance-based stock grant and a related share sale. On February 3, 2026, he acquired 5,770 shares of common stock through a performance share grant under the company’s 2014 Long Term Incentive Plan, valued using the $674.32 NYSE closing price on the vesting date.
On February 4, 2026, he sold 2,665 shares at an average price of $626.33, with prices ranging from $609.29 to $660.49, to cover individual income tax obligations tied to vesting. After these transactions, he directly owned 7,358 shares of Curtiss-Wright common stock.
Curtiss-Wright Corporation’s Chair and CEO Lynn M. Bamford reported equity award vesting and a related share sale. On February 3, 2026, she acquired 20,268 shares of common stock through a performance share grant under the company’s 2014 Long Term Incentive Plan, based on three-year total shareholder return versus peers, using $674.32 as the NYSE closing price on the vesting date.
On February 4, 2026, she sold 9,327 shares of common stock at an average price of $626.45 per share, with the sale described as complying with company share ownership guidelines that allow sales to cover individual income tax obligations from vesting. After these transactions, she directly held 46,192 shares of Curtiss-Wright common stock.
Curtiss-Wright Senior VP & Corp Controller Gary A. Ogilby reported equity award vesting and related share sales. On February 3, 2026, he acquired 1,060 shares of common stock through a performance share grant under the 2014 Long Term Incentive Plan, based on three-year total shareholder return versus a peer group.
Also on February 3, 2026, these shares vested at a reference price of $674.32 per share, the New York Stock Exchange closing price that day. On February 4, 2026, he sold 435 shares at an average price of $626.56, and on February 5, 2026, he sold 625 shares at an average price of $624.32. The filing states that a portion of vested shares was sold in line with company share ownership guidelines to cover income tax obligations, and that the February 5 sale was made under a Rule 10b5-1 trading plan adopted on September 11, 2025.
Following these transactions, Ogilby directly beneficially owned 2,571 shares of Curtiss-Wright common stock.
Curtiss-Wright Corporation director Dean M. Flatt reported acquiring common stock through the company’s 2024 Omnibus Incentive Plan. On January 20, 2026, he acquired 218 shares of common stock at a reference price of $660.66 per share, bringing his directly held stake to 12,647 shares.
The footnotes explain that these shares relate to director compensation earned in 2024, including a portion of his annual restricted stock award, annual retainer, and meeting fees that he elected to receive in stock. Receipt of this portion, equal to 20% of the total annual restricted stock award, retainer, and fees, was deferred and is being paid in five equal annual installments beginning January 15, 2026. The number of shares is based on the closing market prices on the dates the award and fees were approved or earned and includes rounded amounts and dividend credits.
Curtiss-Wright Corporation executive reports small stock sale under pre-set plan. EVP & Chief Growth Officer John C. Watts reported selling 288 shares of Curtiss-Wright common stock on January 8, 2026 at a price of $600 per share. After this transaction, he beneficially owns 3,188 shares directly. The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on August 26, 2025 and was made in line with the company’s share ownership guidelines, which allow sales as long as the executive remains in compliance with those guidelines.
Curtiss-Wright Corporation executive John C. Watts reported a small planned stock sale. On 01/05/2026, he sold 107 shares of Curtiss-Wright common stock at a price of $578.84 per share. After this transaction, he beneficially owned 3,476 shares directly.
The sale was executed under a pre-arranged Rule 10b5-1 trading plan that Watts adopted on August 26, 2025 and was carried out by his financial advisor. The company notes that the shares were sold in line with its share ownership guidelines, which allow sales as long as the executive remains in compliance with those guidelines.
Curtiss-Wright Corporation director Dean M. Flatt reported acquiring additional common stock through deferred director compensation. On January 2, 2026, he acquired 727 shares of Curtiss-Wright common stock at a price of $572.38 per share, recorded as an acquisition. After this transaction, he beneficially owned 12,429 shares directly.
The shares were issued under the company’s 2024 Omnibus Incentive Plan, which allows non-employee directors to defer compensation and receive annual restricted stock awards and fees in stock at a later date. The 727 shares relate to compensation earned in 2018, 2019, 2020, and 2021, with delivery deferred to January 2, 2026, and include dividend credits on outstanding awards.
Curtiss-Wright Corporation director stock award and deferral
A director of Curtiss-Wright Corporation acquired 981 shares of common stock on 01/02/2026, reported as an acquisition transaction. Following this award, the director beneficially owns 5,988 shares directly.
The shares were issued under the company’s 2024 Omnibus Incentive Plan, which allows non-employee directors to defer compensation, including annual restricted stock awards and cash retainers, into stock to be received at a later date. The 981 shares relate to compensation earned in 2022 but deferred until January 2, 2026, with the number of shares determined by dividing the award value by the New York Stock Exchange closing price on the Board’s original approval date and rounded up to the nearest whole share, including related dividend credits. The reported price reference is the $572.38 NYSE closing price as of January 2, 2026.
Curtiss-Wright Corporation executive reports small stock purchase under employee plan. An Executive Vice President and Corporate Secretary of Curtiss-Wright Corporation acquired 21 shares of common stock on 01/05/2026 through the company’s Employee Stock Purchase Plan. The shares were bought at a price of $472.17 per share, based on a 15% discount to the average selling price of the company’s stock on December 31, 2025, the last day of the six-month offering period. Following this transaction, the reporting person beneficially owns 1,947 shares of Curtiss-Wright common stock directly. The transaction is described as exempt under Rules 16b-3(d) and 16b-3(c), reflecting a routine employee purchase rather than an open-market trade.
Curtiss-Wright Corporation executive John C. Watts, EVP & Chief Growth Officer, reported a small share purchase under the company’s Employee Stock Purchase Plan (ESPP). On 01/05/2026, he acquired 13 shares of Curtiss-Wright common stock at a price of $472.17 per share, as shown in Table I of the filing.
The ESPP purchase price reflects a 15% discount to the average selling price of Curtiss-Wright common stock on December 31, 2025, the last day of the six-month offering period. Following this transaction, Watts directly beneficially owns 3,583 shares of Curtiss-Wright common stock. The company notes that this ESPP transaction is exempt under Rule 16b-3(d) and Rule 16b-3(c).
Curtiss-Wright Corporation executive reports share purchase under employee plan. Executive Vice President and COO Kevin M. Rayment acquired 10 shares of Curtiss-Wright common stock on 01/05/2026 through the company’s Employee Stock Purchase Plan (ESPP). The filing states the shares were bought at a price of $472.17 per share, determined with a 15% discount to the average selling price of the company’s common stock on December 31, 2025, the last day of the six-month offering period. Following this transaction, Rayment beneficially owns 25,912 shares of Curtiss-Wright common stock, held directly.